Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

Genetic determinants of circulating GIP and GLP-1 concentrations
Peter Almgren, … , Leif Groop, Emma Ahlqvist
Peter Almgren, … , Leif Groop, Emma Ahlqvist
Published November 2, 2017
Citation Information: JCI Insight. 2017;2(21):e93306. https://doi.org/10.1172/jci.insight.93306.
View: Text | PDF
Research Article Endocrinology Genetics

Genetic determinants of circulating GIP and GLP-1 concentrations

  • Text
  • PDF
Abstract

The secretion of insulin and glucagon from the pancreas and the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) from the gastrointestinal tract is essential for glucose homeostasis. Several novel treatment strategies for type 2 diabetes (T2D) mimic GLP-1 actions or inhibit incretin degradation (DPP4 inhibitors), but none is thus far aimed at increasing the secretion of endogenous incretins. In order to identify new potential therapeutic targets for treatment of T2D, we performed a meta-analysis of a GWAS and an exome-wide association study of circulating insulin, glucagon, GIP, and GLP-1 concentrations measured during an oral glucose tolerance test in up to 7,828 individuals. We identified 6 genome-wide significant functional loci associated with plasma incretin concentrations in or near the SLC5A1 (encoding SGLT1), GIPR, ABO, GLP2R, F13A1, and HOXD1 genes and studied the effect of these variants on mRNA expression in pancreatic islet and on metabolic phenotypes. Immunohistochemistry showed expression of GIPR, ABO, and HOXD1 in human enteroendocrine cells and expression of ABO in pancreatic islets, supporting a role in hormone secretion. This study thus provides candidate genes and insight into mechanisms by which secretion and breakdown of GIP and GLP-1 are regulated.

Authors

Peter Almgren, Andreas Lindqvist, Ulrika Krus, Liisa Hakaste, Emilia Ottosson-Laakso, Olof Asplund, Emily Sonestedt, Rashmi B. Prasad, Esa Laurila, Marju Orho-Melander, Olle Melander, Tiinamaija Tuomi, Jens Juul Holst, Peter M. Nilsson, Nils Wierup, Leif Groop, Emma Ahlqvist

×

Total citations by year

Year: 2023 2022 2021 2020 2019 2018 Total
Citations: 6 2 4 3 2 1 18
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (18)

Title and authors Publication Year
Whole-Exome Sequencing in Family Trios Reveals De Novo Mutations Associated with Type 1 Diabetes Mellitus.
Mousa M, Albarguthi S, Albreiki M, Farooq Z, Sajid S, El Hajj Chehadeh S, ElBait GD, Tay G, Deeb AA, Alsafar H
Biology 2023
Genetically proxied impaired GIPR signaling and risk of 6 cancers
Rogers M, Gill D, Ahlqvist E, Robinson T, Mariosa D, Johansson M, Cortez Cardoso Penha R, Dossus L, Gunter MJ, Moreno V, Davey Smith G, Martin RM, Yarmolinsky J
iScience 2023
GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification.
Lagou V, Jiang L, Ulrich A, Zudina L, González KSG, Balkhiyarova Z, Faggian A, Maina JG, Chen S, Todorov PV, Sharapov S, David A, Marullo L, Mägi R, Rujan RM, Ahlqvist E, Thorleifsson G, Gao Η, Εvangelou Ε, Benyamin B, Scott RA, Isaacs A, Zhao JH, Willems SM, Johnson T, Gieger C, Grallert H, Meisinger C, Müller-Nurasyid M, Strawbridge RJ, Goel A, Rybin D, Albrecht E, Jackson AU, Stringham HM, Corrêa IR Jr, Farber-Eger E, Steinthorsdottir V, Uitterlinden AG, Munroe PB, Brown MJ, Schmidberger J, Holmen O, Thorand B, Hveem K, Wilsgaard T, Mohlke KL, Wang Z, Shmeliov A, den Hoed M, Loos RJF, Kratzer W, Haenle M, Koenig W, Boehm BO, Tan TM, Tomas A, Salem V, Barroso I, Tuomilehto J, Boehnke M, Florez JC, Hamsten A, Watkins H, Njølstad I, Wichmann HE, Caulfield MJ, Khaw KT, van Duijn CM, Hofman A, Wareham NJ, Langenberg C, Whitfield JB, Martin NG, Montgomery G, Scapoli C, Tzoulaki I, Elliott P, Thorsteinsdottir U, Stefansson K, Brittain EL, McCarthy MI, Froguel P, Sexton PM, Wootten D, Groop L, Dupuis J, Meigs JB, Deganutti G, Demirkan A, Pers TH, Reynolds CA, Aulchenko YS, Kaakinen MA, Jones B, Prokopenko I
Nature Genetics 2023
Specific Genotypes Associated with Differences in Fasting Insulin Levels and Body Mass Index in Healthy Young Males: Implications for Gene–Nutrient Interactions—an Exploratory Study
Brown JE, Pham T, Burden H, Braakhuis AJ
2023
Spatiotemporal regulation of GIPR signaling impacts glucose homeostasis as revealed in studies of a common GIPR variant
Yammine L, Picatoste B, Abdullah N, Leahey RA, Johnson EF, Gómez-Banoy N, Rosselot C, Wen J, Hossain T, Goncalves MD, Lo JC, Garcia-Ocaña A, McGraw TE
Molecular Metabolism 2023
Potential determinants of low circulating glucagon-like peptide 2 concentrations in Zambian children with non-responsive stunting.
Besa E, Tembo MJ, Mulenga C, Mweetwa M, Choudhry N, Chandwe K, Storer C, Head R, Amadi B, Haritunians T, McGovern D, Kwenda G, Peiris M, Kelly P
Experimental Physiology 2023
Genetic variation in sodium glucose co‐transporter 1 and cardiac structure and function at middle age
A Bavishi, L Colangelo, L RasmussenTorvik, J Lima, D Nannini, M Vaduganathan, A Pandey, D LloydJones, S Shah, R Patel
ESC Heart Failure 2022
Hyperglucagonemia in Pediatric Adiposity Associates With Cardiometabolic Risk Factors but Not Hyperglycemia
Stinson SE, Jonsson AE, de Retana Alzola IF, Lund MA, Frithioff-Bøjsøe C, Aas Holm L, Fonvig CE, Pedersen O, Ängquist L, Sørensen TI, Holst JJ, Christiansen M, Holm JC, Hartmann B, Hansen T
The Journal of clinical endocrinology and metabolism 2022
Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits
KA Meeks, AR Bentley, MH Gouveia, G Chen, J Zhou, L Lei, AA Adeyemo, AP Doumatey, CN Rotimi
Genome Medicine 2021
Genome-wide association study of circulating levels of glucagon during an oral glucose tolerance test
A Jonsson, SE Stinson, SS Torekov, TD Clausen, K Færch, L Kelstrup, N Grarup, ER Mathiesen, P Damm, DR Witte, ME Jørgensen, O Pedersen, JJ Holst, T Hansen
BMC Medical Genomics 2021
Genetically Predicted Glucose-Dependent Insulinotropic Polypeptide (GIP) Levels and Cardiovascular Disease Risk Are Driven by Distinct Causal Variants in the GIPR Region
N Bowker, R Hansford, S Burgess, CN Foley, VP Auyeung, AM Erzurumluoglu, ID Stewart, E Wheeler, M Pietzner, F Gribble, F Reimann, P Bhatnagar, MP Coghlan, NJ Wareham, C Langenberg
Diabetes 2021
Cross-platform genetic discovery of small molecule products of metabolism and application to clinical outcomes
Lotta LA, Pietzner M, Stewart ID, Wittemans LB, Li C, Bonelli R, Raffler J, Biggs EK, Oliver-Williams C, Auyeung VP, Luan J, Wheeler E, Paige E, Surendran P, Michelotti GA, Scott RA, Burgess S, Zuber V, Sanderson E, Koulman A, Imamura F, Forouhi NG, Khaw KT, Griffin JL, Wood AM, Kastenmüller G, Danesh J, Butterworth AS, Gribble FM, Reimann F, Bahlo M, Fauman E, Wareham NJ, Langenberg C
Nature Genetics 2021
Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective study
A Jujić, N Atabaki-Pasdar, PM Nilsson, P Almgren, L Hakaste, T Tuomi, LM Berglund, PW Franks, JJ Holst, RB Prasad, SS Torekov, S Ravassa, J Díez, M Persson, O Melander, MF Gomez, L Groop, E Ahlqvist, M Magnusson
Diabetologia 2020
Human postprandial responses to food and potential for precision nutrition
SE Berry, AM Valdes, DA Drew, F Asnicar, M Mazidi, J Wolf, J Capdevila, G Hadjigeorgiou, R Davies, HA Khatib, C Bonnett, S Ganesh, E Bakker, D Hart, M Mangino, J Merino, I Linenberg, P Wyatt, JM Ordovas, CD Gardner, LM Delahanty, AT Chan, N Segata, PW Franks, TD Spector
Nature Medicine 2020
Glucose-Dependent Insulinotropic Peptide in the High-Normal Range Is Associated With Increased Carotid Intima-Media Thickness
A Jujić, P Nilsson, N Atabaki-Pasdar, A Dieden, T Tuomi, P Franks, J Holst, S Torekov, S Ravassa, J Díez, M Persson, E Ahlqvist, O Melander, M Gomez, L Groop, M Magnusson
Diabetes care 2020
Gene x Gene Interactions Highlight the Role of Incretin Resistance for Insulin Secretion
BA Jaghutriz, M Heni, SZ Lutz, L Fritsche, F Machicao, H Staiger, A Peter, HU Häring, A Fritsche, R Wagner
Frontiers in Endocrinology 2019
Deciphering The Potential Role of Hox Genes in Pancreatic Cancer
TL Kuo, KH Cheng, LT Chen, WC Hung
Cancers 2019
Genome-wide meta-analysis of macronutrient intake of 91,114 European ancestry participants from the cohorts for heart and aging research in genomic epidemiology consortium
J Merino, HS Dashti, SX Li, C Sarnowski, AE Justice, M Graff, C Papoutsakis, CE Smith, GV Dedoussis, RN Lemaitre, MK Wojczynski, S Männistö, JS Ngwa, M Kho, TS Ahluwalia, N Pervjakova, DK Houston, C Bouchard, T Huang, M Orho-Melander, AC Frazier-Wood, DO Mook-Kanamori, L Pérusse, CE Pennell, PS de Vries, T Voortman, O Li, S Kanoni, LM Rose, T Lehtimäki, JH Zhao, MF Feitosa, J Luan, NM McKeown, JA Smith, T Hansen, N Eklund, MA Nalls, T Rankinen, J Huang, DG Hernandez, CA Schulz, A Manichaikul, R Li-Gao, MC Vohl, CA Wang, FJ van Rooij, J Shin, IP Kalafati, F Day, PM Ridker, M Kähönen, DS Siscovick, C Langenberg, W Zhao, A Astrup, P Knekt, M Garcia, DC Rao, Q Qi, L Ferrucci, U Ericson, J Blangero, A Hofman, Z Pausova, V Mikkilä, NJ Wareham, SL Kardia, O Pedersen, A Jula, JE Curran, MC Zillikens, JS Viikari, NG Forouhi, JM Ordovás, JC Lieske, H Rissanen, AG Uitterlinden, OT Raitakari, JC Jong, J Dupuis, JI Rotter, KE North, RA Scott, MA Province, M Perola, LA Cupples, ST Turner, TI Sørensen, V Salomaa, Y Liu, YJ Sung, L Qi, S Bandinelli, SS Rich, R de Mutsert, A Tremblay, WH Oddy, OH Franco, T Paus, JC Florez, P Deloukas, LP Lyytikäinen, DI Chasman, AY Chu, T Tanaka
Molecular Psychiatry 2018

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts